| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |